Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v60-EN Version v59-FR
Language English French
Date Updated 2018-10-10 2018-10-09
Drug Identification Number 02293269 02293269
Brand name CAMPRAL CAMPRAL
Common or Proper name CAMPRAL CAMPRAL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ACAMPROSATE CALCIUM ACAMPROSATE CALCIUM
Strength(s) 333MG 333MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 84BL 84BL
ATC code N07BB N07BB
ATC description DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-07-17 2018-07-17
Actual start date 2018-07-03 2018-07-03
Estimated end date 2018-10-09 2018-10-09
Actual end date 2018-10-09 2018-10-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments